Team Leader (USP)

PD Dr. Yvonne Genzel
PD Dr. Yvonne Genzel
Phone: +49 391 6110 257
Room: N0.18

Researcher

Juliana Coronel, D.Sc.
Phone: +49 391 6110 256
Room: N0.05
Links: Linkedin
Gwendal Gränicher, M. Sc.
Gwendal Gränicher, M. Sc.
Phone: +49 391 6110 333
Room: N 0.07

Additional Information

Internal Collaborations:

P. Marichal-Gallardo, M. Sc. Downstream Processing, BPE, MPI Magdeburg

A. Nikolay, M. Sc. Upstream Processing, BPE, MPI Magdeburg

A. Pralow, M. Sc. Bio/Process Analytics, BPE, MPI Magdeburg

External Collaborations:

ProBioGen AG, Berlin, Germany (Dr. V. Sandig)

Sine Phase Instruments GmbH, Mödling, Austria (Dr. F. Trampler)

Bielefeld University, Bielefeld, Germany (Prof. T. Noll)

Kühner AG, Birsfelden (Basel), Switzerland (Dr. T. Anderlei)

Production of Viral Vaccines in High-Cell-Density Suspension Cultures

Header image 1378194284

Production of Viral Vaccines in High-Cell-Density Suspension Cultures

Motivation

Process intensification for the production of various animal cell culture-based biopharmaceuticals relies on high-cell-density (HCD) cultures. While processes in perfusion mode are commonly applied for manufacturing of recombinant proteins [1], the production of viral vaccines under HCD conditions has been little explored, so far. In part, this is due to the often significant decrease in cell-specific yields (virus particles/cell) and/or a low volumetric productivity (virus particles/L·d) compared to conventional batch processes – also called “cell density effect” [2, 3]. Furthermore, virus-induced apoptosis and cell death render continuous virus production strategies in perfusion mode challenging. Nevertheless, to increase virus yields, the use of advanced process strategies suitable to overcome the intrinsic challenges of virus propagation in HCD cultures should be promoted. This concerns in particular hybrid perfusion/fed-batch processes [4]. In addition, available cell retention devices should be better characterized regarding host cell retention and cell-virus separation.

Aims of the project

  • Evaluation of different retention systems for HCD suspension cell culture in viral vaccine production
  • Comparison of possible feeding strategies during cell growth and virus replication phase for maximum yields taking into account subsequent downstream processing steps
  • Monitoring of critical process parameters to characterize cell growth and virus replication dynamics
  • Analysis of the impact of medium composition on virus quality and process yields
  • Identification of critical parameters for integration of upstream and downstream operations

References

1.
Kompala, D.S; Ozturk, S.S.:
Optimization of high cell density perfusion bioreactors.
2.
Genzel, Y.; Vogel, T.; Buck, J.; Behrendt, I.; Vazquez-Ramirez, D.; Schiedner, G.; Jordan, I.; Reichl, U.: High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells. Vaccine 32 (24), pp. 2770 - 2781 (2014)
3.
Vazquez-Ramirez, D.; Genzel, Y.; Jordan, I.; Sandig, V.; Reichl, U.: High-cell-density cultivations to increase MVA virus production. Vaccine 36 (22), pp. 3124 - 3133 (2018)
4.
Vázquez-Rámirez, D. et al.
A hybrid fed-batch/perfusion process to increase productivity of high-cell density cultivations in vaccine manufacturing.

 
Go to Editor View
loading content